You Already Know
About the 80%.
Here's What I Didn't
Put in the Post.
Three things I left out — because the post was already long, and I wasn't sure people would believe them without seeing the actual research first.
If you read the full account, you know where things stand with Gary.
What I didn't include — because I wasn't sure how to say it without sounding like I was overselling something — are the three things that actually pushed me off the fence.
These are the reason I went from "interesting, I'll think about it" to throwing the Atorvastatin prescription in the trash the next morning.
after the barbecue ended
Everyone had left. I was helping stack chairs. Dave came back out with two beers.
He'd shown me his labs — LDL 182 to 89. I thought the conversation was over.
He sat down and said something I hadn't expected.
"I want to tell you something I probably shouldn't."
— Dave, retired cardiologist · Johns HopkinsHe'd had a patient. Sixty-three years old. Managed LDL for nine years. Came in for a routine follow-up. Bloodwork looked perfect. Dave told him everything was under control.
Three weeks later the man's wife called his office.
"He didn't hold me responsible," Dave said. "But I've thought about it almost every day since."
He looked at his beer for a moment.
"His LDL was 114 when he died."
"When I found the Okinawa research after I retired, the first thing I thought about was him. Not my own labs. Him."
"That's why I tested it on myself before I told anyone else. I needed to know it was real before I put that on somebody."
I didn't include this in the post because I didn't want it to read like a scare tactic. But if you've read everything else — you deserve the honest version of why Dave cares about this the way he does.
It's not academic. It's personal.
on night three
I mentioned she spent three nights at the kitchen table. I didn't say what she found on the last night.
She'd been tracking down the original Okinawa population studies — the ones that identified why cardiovascular mortality in that region runs roughly five times lower than the American average.
She found something the secondary sources weren't talking about.
They didn't set out to study cholesterol. They were studying why people in a specific region were reaching 90 and 100 in physical condition that didn't match their age.
Cholesterol numbers were almost incidental. What they kept finding was that the bile-binding mechanism wasn't just affecting LDL. The people with the highest intake of these specific mushroom species were also showing measurably lower systemic inflammation, better arterial elasticity, and cognitive function scores that tracked a decade younger than their chronological age.
The cholesterol result was real. But it was downstream of something broader happening at the cellular level.
She closed her laptop at 1 AM and came upstairs.
"It's not a cholesterol thing," she said. "Cholesterol is just what they measure. What it's actually doing is older than that."
I've been thinking about that sentence for six months.
the berberine company
I mentioned I called them when my LDL went up six points. I didn't mention what happened after.
About a week later, someone from their customer service team emailed me a follow-up.
Not an apology. Not a refund offer.
A list of studies showing berberine "supports healthy cholesterol metabolism."
Every single study on that list used 1,500mg daily. I had been taking 500mg. The studies they sent me as proof their product worked were the exact same studies that proved it couldn't work at the dose they sold.
I printed the email and the studies. Brought them to Dave.
He read through them. Set the papers down.
"This is standard practice in this industry. The research is real. The dose on the label is not."
He tapped the stack of papers.
"This is why I tested fourteen brands before I mentioned any of this to anyone. And this 일 why the cold-extraction matters as much as the species. You can have the right mushrooms at the right concentration and destroy the fiber structure in processing. It becomes the same problem."
He handed the papers back.
"The video I sent you explains the extraction process better than I can in a conversation. I'd watch that before you look at anything else."
That was the moment I understood why Dave had spent that much time verifying this before mentioning it to anyone.
There's one more thing — and I can't explain this one in text.
When Dave sent me the link, I expected a sales presentation. What I got was the closest thing I've seen to sitting in a room with someone who spent two years reading research most people will never have access to — and watching him walk through exactly what he found, in the order he found it.
The part starting around the twelve-minute mark is the reason Gary's wife called me.
I'm not going to summarize it. It doesn't summarize well. But if you've read everything up to here, you'll know within the first few minutes whether this is worth your time.
It is.
But off the record — this is what I take."
No signup · No obligation · Sound recommended
P.S. — Gary's wife asked me to add something. She said I could quote her directly: "I have my husband back. Not the numbers. Him." She wanted anyone reading this to know that the thing that changed wasn't on a lab report.
P.P.S. — Dave mentioned one practical thing to pass along. The formula is made in small batches — cold extraction at pharmaceutical grade takes significantly longer than standard processing. He's had to wait for restocks before. If you're planning to check your labs in the next 60 days, he said not to wait on this.
P.P.P.S. — The 365-day guarantee is explained in the video. I'll just say this: it exists because the researchers behind this know what the bloodwork looks like at week eight. They built the guarantee around that window. That's not a marketing decision. That's a confidence decision.